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Nanotechnology is a rapidly emerging technology dealing with so-called nanomaterials which at least in one dimension have size
smaller than 100 nm. One of the most potentially promising applications of nanotechnology is in the area of tissue engineering,
including biofabrication of 3D human tissues and organs. This paper focused on demonstrating how nanomaterials with nanolevel
size can contribute to development of 3D human tissues and organs which have macrolevel organization. Specific nanomaterials
such as nanofibers and nanoparticles are discussed in the context of their application for biofabricating 3D human tissues and
organs. Several examples of novel tissue and organ biofabrication technologies based on using novel nanomaterials are presented
and their recent limitations are analyzed. A robotic device for fabrication of compliant composite electrospun vascular graft is
described. The concept of self-assembling magnetic tissue spheroids as an intermediate structure between nano- and macrolevel
organization and building blocks for biofabrication of complex 3D human tissues and organs is introduced. The design of in
vivo robotic bioprinter based on this concept and magnetic levitation of tissue spheroids labeled with magnetic nanoparticles is
presented. The challenges and future prospects of applying nanomaterials and nanotechnological strategies in organ biofabrication
are outlined.
1. Introduction
Biofabrication may be defined as an application principle of
engineering and information sciences for automated robotic
bioassembly of living 3D human tissue and organs [1–3]. In
a more narrow sense, biofabrication is basically a biomedical
application of rapid prototyping technology or computer-
aided additive fabrication. Although biofabrication is closely
related to the more established field of tissue engineering and
could even be considered as an integral part of this broader
field, biofabrication focuses on and emphasizes using robotic
automated engineering approaches in tissue bioassembly. In
this context, the recent situation in tissue engineering and
biofabrication could be compared to the situation of the
microelectronic industry before and after the introduction
of automated robotic technologies for fabricating microchips
and microprocessors. The transformation of the labor
intensive and still predominantly manual field of tissue
engineering into a robotic automated industry needs inno-
vative and creative approaches. The history of technology
development teaches us that one of the important principles
that contribute to the emergence of a new technology is
the creative application of knowledge from other disciplines
outside the narrow domain of an existing technology. It is
also a well-established fact that robotization and automation
help to transform emerging promising technologies into
economically feasible industries.
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Nanotechnology is one of the most promising technolo-
gies of the XXI century. During last decade we witnessed
the exponentially growing applications of nanotechnology
in the area of tissue engineering [4–12]. Tissue engineering
meetings and conferences now regularly include nanotech-
nology sessions. The number of nanotechnology-related
papers in tissue engineering journals and tissue-engineering-
related papers in nanotechnology journal has also dra-
matically increased especially during last decade. Finally,
recent reviews on nanotechnology applications in tissue
engineering are another confirmation of this trend [13–22].
However, it is not immediately obvious how nanomaterials
with nanolevel organization could be used for biofabricating
3D tissue and organs which have macrolevel of organization.
In other words, application of nanotechnology does not
reduce existing size of human organs. However, the review
of already existing and emerging approaches can provide
interesting insights on probably the most important and
nontrivial question on the interface of nanotechnology and
tissue engineering: how employment of nanomaterials can
enable biofabrication of human organs on macrolevel?
Thus, this paper is focused on demonstrating how recent
advances in application of nanomaterials in tissue engineer-
ing can enable robotic and automated biofabrication of 3D
human tissues and organs. The most impressive examples
of emerging robotic tissue and organ biofabrication devices
and related technologies will be presented. Finally, challenges
and future prospects of application of nanomaterials in
tissue engineering and nanotechnological strategies in organ
biofabrication will be outlined.
2. Nanofibers
Over the last two decades, electrospinning has emerged as
a relatively simple and scalable nanotechnological method
for the generation of nanostructured scaffolds that closely
mimic the dimensions of collagen fibrils of ECM. The general
aspects of this technology have been reviewed extensively
elsewhere [15, 23–25]. We will focus our attention here on
the accomplishments and challenges in the utilization of
electrospinning technology in the field of vascular tissue
engineering.
A broad spectrum of synthetic polymers has been
successfully employed in electrospinning. Moreover, electro-
spinning of natural proteins, such as collagen and elastin,
either alone or in combinations, as well as in blends with
synthetic polymers, has been reported [23, 26–29]. However,
it is naive to believe that imitating the relative compositions
of structural proteins, such as collagen and elastin, in natural
vascular walls would lead to the development of vascular
scaffolds with natural-like biomechanical properties. Indeed,
the reported stability of vascular scaffolds created by electro-
spinning of only natural proteins is still far from desirable
levels [27].
It has been demonstrated that electrospinning allows the
control of the diameter of the spun fibers and produces
nanofibers and scaffolds that imitate the nanostructure of
natural ECMs, as confirmed by a more efficient vascular
cell attachment and spreading [27–31]. Although dense
nanofiber meshworks provide excellent conditions for cell
attachment and the spreading of endothelial cells on the
luminal surface of the scaffold [30], they also preclude
effective cell migration into the scaffold and thus impede
smooth muscle cell migration and the sequential formation
of muscular layers inside the vascular tissue engineered
constructs.
Electrospinning allows the fabrication of a large variety
of nanofibers and nanostructured scaffolds with special
characteristics and functionalities (Figure 1). The obtained
nanofibers vary in size, shape, and composition: they can
be solid, composite, hollow, porous, decorated, helical, and
branched. This diversity of possible electrospun nanofibers
offers interesting opportunities for the enhancement of
vascular-scaffold functionality. For example, the hollow
nanofibers and nanoshells created by a coaxial extruder,
as well as composite-coated or decorated nanofibers, could
provide additional functionalities, including the capacity
to release oxygen and to present growth factors and RGD
peptides [32]. However, the full potential of electrospinning
for the engineering of the full array of nanofibers with
different functionalities remains to be explored.
Significant progress has already been made in controlling
fiber orientation [33], which is an important step toward the
rational design of biomimetic vascular scaffolds. However,
in our opinion, controlling only the orientation of the
nanofiber will probably not be sufficient. The recapitulation
of the entire matrix architecture and the nonlinear biome-
chanical behavior of the natural vascular wall are equally
crucial.
The most exciting breakthrough in electrospinning is
the successful one-step rapid fabrication of a vascular
scaffold with integrated living cells [34]. In these stud-
ies, previously reported methods for the encapsulation of
living cells were combined with the electrospinning of
nanofibers into one procedure. Further optimization of this
electrospinning strategy might offer the greatest potential
for rapid biofabrication of vascular-tissue constructs and
might eventually eliminate the need for time-consuming and
expensive bioreactor-based cell seeding and scaffold cellular-
ization. Despite this impressive progress in vascular tissue
engineering with the help of innovative electrospinning
technologies, rapid cell integration into scaffolds and their
optimal mechanical properties remain the main challenges.
Due to mimicking geometrical size and organization of
natural extracellular matrix fibers, the electrospun matrices
are ideal substrates for growing and implantation of cell
monolayers and can even compete with popular cell sheet
technology developed by Teruo Okano group in Japan [35].
Their main advantage is strong potential for functional-
ization and turning them into drug eluting matrices and
scaffold. However, in case of 3D tissue engineering despite
the existence of numerous publications and patents on using
electrospinning in tissue engineering, we have paradoxical
situation. Electrospun matrices are not permissive for cell
invasion and seeding and their gross material properties
are inferior. Scaffold which is not permissive for effective
cell seeding and which has poor material properties is not
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Figure 1: Nanofibers: electrospinning nanotechnology. (a) Scheme demonstrating principle of electrospinning technology and
electrospinning apparatus; (b) Electrospun tissue engineered scaffold (scanning electron microscopy), (c) Scheme demonstrating different
diverse classes of nanofibers that can be obtained by electrospinning. Shown are, from left to right, solid, core-shell, hollow, porous,
composite, decorated, spiral, and branched nanofibers [3].
highly desirable scaffold in tissue engineering. These two still
unsolved problems are main impediments on the way of
successful clinical application of electrospun matrices from
nanofibers.
In recent excellent review the first problem was very
carefully addressed. It looks like it is possible to create large
pore scaffold permissive for cell seeding using additional
electrospinning sacrificial polymers or cryoelectrospinning
[36].
We have recently developed an elegant solution for the
second problem-creating electrospun scaffold with superior
natural-like gross material properties using hybrid composite
approach. In order to accomplish this, a special fabrication
apparatus has been developed which includes a X-Y-Z robot
with two nozzles allowing using two different polymers and
a rotational collecting cylinder with periodically changeable
diameter enabling formation of wavy nanofibers (Figure 2).
Development of an “out-of-shelf” compliant composite
electrospun vascular graft will be important development in
the application of nanofibers in vascular tissue engineering.
Combination of compliant composite electrospun scaf-
fold with the use of coaxial electrospinning will allow creat-
ing also drug eluting vascular graft which in case of clinical
success could be considered a very important development
in the application of electrospinning in tissue engineering.
Finally, another interesting breakthrough development is the
combination of electrospinning with rapid prototyping, and
developing hybrid composite technology, which allows to
dramatic increasing of the bioprinted scaffold properties
[37]. Thus, using nanofibers fabricated by the electrospin-
ning method offers realistic opportunities to enhance tissue
engineering.
3. Nanoparticles
There are at least several rapidly emerging nanotechnological
strategies for using nanoparticles in tissue engineering [13–
15, 38–40]. They are mostly based on employing magnetic
nanoparticles. The emerging platform technology was
named as magnetic-forces-driven tissue engineering [41]. It
is important to indicate that living cells can endocytize mag-
netic nanoparticles without strong toxic effect (Figure 3).
Moreover, at least one type of superparamagnetic iron
oxide nanoparticles known as “Feridex” has been already
approved for clinical use as a MRI contrast enhancing agent.
First strategy is magnetic-forces-enhanced cell seeding of
tissue-engineered scaffold. In certain extent this approach
is similar to enhancing cell seeding using centrifugal forces.
The principal difference is that driven force is not centrifugal
forces but magnetic field forces that translocate cells labeled
with magnetic nanoparticles. It has been demonstrated that
using this technology dramatically accelerates and improves
both speed and quality of cell seeding in porous tissue
engineered biodegradable scaffolds [42–44]. One of the most
interesting areas of application of magnetic-force-driven cell
seeding is vascular tissue engineering. Several groups around
the world independently developed rapid magnetic-force-
based cell seeding technologies for vascular graft and scaffold
[39, 40] summarized and illustrated on Figure 4.
The second strategy is based on using magnetic forces
and so-called “nanoshuttle” for biofabrication and bioassem-
bly of tissue spheroids [45]. However, in the reported
approach the size of fabricated tissue spheroids is variable.
In this context, the reported technology is still inferior
as compared to other tissue spheroids biofabrication, but
elegant simplicity of this method is attractive and it could
be optimized. It is interesting that authors suggested to
use their “nanoshuttle” method for magnetic-forces-based
biofabrication histological structure of complex geometry
[45]. Tissue spheroids fabricated from living cells labeled by
magnetic nanoparticles have been used for patterning and
assembly of 3D patterns by several groups [46, 47]. The way
how magnetic force can be used for layer-by-layer fabrication
of a 3D structure has been recently demonstrated by George
Whiteside group from Harvard University [48]. Another
group from the same University used hydrogel labeled with
nanoparticles for successful assembly of a 3D living structure
[49]. However, the most advanced published record in using









Figure 2: Robotic fabricator of compliant composite electrospun vascular graft. (a) Computer-aided design of rotational collecting cylinder
with periodically changing external diameter; (b) Computer-aided design of robotic fabricator of compliant composite electrospun vascular
graft (c) Confocal microscopy of compliant vascular graft fabricated from wavy (green) and nonwavy nanofibers (red); (d) Scheme explaining
biomimetic mechanical behavior of compliant composite electrospun vascular graft.
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Figure 3: Nanoparticles. Labeling of cells with nanoparticles for magnetic-driven tissue engineering [3]: (a) Transmission electron
micrograph of a typical population of metallic nanoparticles; (b) Light micrograph of human mesenchymal cells derived from bone marrow,
which are capable of vascular lineage differentiation. The cells have been labeled with superparamagnetic iron oxide nanoparticles. Staining
with Prussian Blue indicates the presence of nanoparticles inside of cells. (c) Transmission electron micrograph of human endothelial cells
that were labeled with nanoparticles. White arrows indicate clusters of nanoparticles that had been endocytosed inside the cell.
nanoparticles for biofabrication of diverse human tissues
belongs to members of Japanese group [41] who are pioneers
of magnetic-force-driven tissue engineering. These authors,
using magnetic forces driven tissue engineering, were able to
fabricate functional epithelial, myocardial, skeletal muscle,
skin, liver tissue and many other tissues. Finally, there is
an emerging third approach which represents probably the
most interesting strategy of using nanoparticles in tissue
engineering. We are talking about certain attempts of using
nanoparticles in bioprinting process [50]. Up to now, these
attempts are still limited to incorporating nanoparticles in
bioprintable hydrogels [50]. However, as it was proposed
in our previous review publication using magnetic force
and specially fabricated magnetic tissue spheroids could
eventually lead to the development of a bioprinter based on
principles of magnetic levitation [15]. Another interesting
approach is a fabrication janus-like tissue spheroids [51],
which enables self-directed self-assembly of tissue spheroids
in linear, circular, and branched structures (Figure 5).
4. Nanotechnology and Organ Printing
Organ printing is a biomedical variant of rapid prototyping
technology or computer-aided robotic layer-by-layer addi-
tive biofabrication of 3D human tissues and organs using
self-assembling tissue spheroids as building blocks [52–
54]. The fundamental basic principle of organ bioprinting
technology is the phenomenon of tissue fusion of closely
placed tissue spheroids. The tissue fusion process is driven
by physical forces such as surface tension and implies






Figure 4: Magnetic-forces-driven vascular tissue engineering. The schematic illustrations shown above present three possible variations of
magnetic-driven vascular tissue engineering, depending on the cells used and the placement of the vascular scaffold. In the first arrangement
(a), the magnet (purple) is placed outside of the vascular scaffold and cells labeled with magnetic nanoparticles (green) are placed into
the lumen. The magnet force causes the endothelial cells to adhere to and spread on the luminal surface of the vascular scaffold with the
subsequent formation of a continuous endothelial monolayer. The second variation (b) is similar to the previous in that the magnet (purple)
is placed outside of the scaffold (grey), but smooth muscle (red) and endothelial cells (green), both labeled with magnetic nanoparticles, are
sequentially placed into the lumen for rapid adhesion and cellularization. In the third variation (c), the magnet (purple) is placed inside the
vascular scaffold (grey) and smooth muscle cells labeled with magnetic nanoparticles (red) are placed outside of the scaffold. Rotation of the
magnet enables the cell attachment with the subsequent formation of a concentric layer of smooth muscle cells on the external surface of the




Figure 5: Fabrication of janus-like self-assembling tissue spheroids with magnetic nanoparticles. (a) Scheme demonstrating biofabrication
of janus-like tissue spheroids using microfluidics [51]; (b) Janus-like spheroids fabricated by microfluidics devices [51]; (c) Scheme
demonstrating magnetic-forces-driven self-directed self-assembly of closely placed janus-like magnetic tissue spheroids; (d) Branched
structure formed as a result of fusion of closely placed tissue spheroids [52].
viscoelastic-plastic physical nature of tissue spheroids. How-
ever, when tissue spheroids under influence of inductive
signal differentiate into so-called “osteospheres” or “chon-
drospheres,” then their material properties also change and
their capacities for rapid tissue fusion are dramatically
reduced. In order to escape this problem we have designed
and developed interlockable miniscaffold or “lockyballs”
which can interlock using specially designed “hook” and
“lops” mechanism similar to famous Velcro and thus provide
desirable material properties for 3D tissue constructs. Locky-
balls also can contain encaged tissue spheroids which will still
have capacities for tissue fusion. The opposite is the situation
when tissue spheroids are fusing too fast even before the
actual bioprinting process. In order to prevent this situation,
encapsulation in thin layer of sacrificial hydrogel is desirable.
Thus, bioprinter can be loaded with three variant of tissue
spheroids: (i) free tissue spheroids; (ii) tissue spheroids
encapsulated in hydrogel; and (iii) tissue spheroids encaged
into lockyballs or miniscaffold (Figure 6).
Now, if one wants to employ the magnetic levitation
principle in the design of a robotic bioprinter for har-
vesting, translocating and delivery of tissue spheroids then
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Figure 6: Enabling technologies for magnetic levitation of tissue spheroids. Three possible variants of modifications of tissue spheroids
making them suitable for magnetic levitation: (a) biofabrication of tissue spheroid from cells labelled with magnetic nanoparticles; (b)
encapsulation of tissue spheroid into hydrogel containing magnetic nanoparticles; (c) encaging tissue spheroid in magnetic microscaffolds.
(a) (b) (c) (d)
(e)
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Figure 7: “Lockyballs” or interlockable microscaffolds for encaging living tissue spheroids. (a) Computer-aided design of lockyball; (b) Light
microscopy of lockyball; (c) Confocal microscopy of lockyball; (d) Scanning electron microscopy of lockyball; (e) Different design variants
of lockyball “hooks” which can be used as interlocking mechanism; (f) Section of lockyballs demonstrating magnetic nanoparticles inside;
(g) Lockyball with magnetic nanosurface; (h) Section of lockyball demonstrating functionalization with nanoparticles on external surface.
nanotechnology can offer at least three basic approaches:
(i) magnetic tissue spheroids could be biofabricated from
cells labeled with magnetic nanoparticles; (ii) magnetic tissue
spheroids can be fabricated from tissue spheroids encapsu-
lated in hydrogel loaded with magnetic nanoparticles; and,
finally, (iii) magnetic tissue spheroids can be fabricated by
providing magnetic properties to miniscaffold or lockyballs
encaging these tissue spheroids (Figure 7).
At least three different approaches may be adopted
to obtain magnetic lockyballs. First, by placing magnetic
nanoparticles inside a photosensitive polymer before two
photon polymerization steps; second, by coating the lock-
yballs surface with a magnetic nanosurface; or third, by
coating it with immobilized magnetic nanoparticles. All
three approaches at least can make lockyballs and tissue
spheroids encaged inside them suitable for magnetic levita-
tion (Figure 8).
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Figure 8: Robotic tissue spheroids biofabricator. (a) Scheme demonstrating sequential steps of encaging tissue spheroids in microscaffold




Figure 9: Design elements of a clinical robotic bioprinter. (a) Tissue spheroids harvester based on magnetic levitation of tissue spheroids;
(b) Principal scheme of clinical robotic bioprinter demonstrating how tissue spheroids can be harvested from multiwells, translocated
and dispensed in living tissue using magnetic levitation; (c) Elegant robotic hand developed by group of robotics and mechanotronics
at German Aerospace Institute (http://www.dlr.de/rm/en/desktopdefault.aspx/tabid-3803/6175 read-8961/) which can be employed as an
essential component in robotic clinical bioprinter for automated nozzle positioning; (d) Computer-aided design of nozzle of clinical robotic
bioprinter containing several channels: two channels for fibrinogen and thrombin, one channel for tissue spheroids and additional channel
for pressurized air for enabling fibrin hydrogel spraying.
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The conceptual design of an in vivo robotic bioprinter
based on the principle of magnetic levitation is presented on
Figure 9. Magnetic forces driven in vivo bioprinter must have
a magnetic harvesting device (magnetic solenoid) controlled
by an X-Y-Z robot, a magnetic translocating device, and
a magnetic dispensing nozzle controlled manually or by
a robotic hand (Figure 9). The nozzle will include two
channels for fibrinogen and thrombin, one or more channels
for dispensing tissue spheroids (or different type of tissue
spheroids) and one or more channels providing pressurized
air which will enable spraying fibrin hydrogel. The potential
areas of clinical application of such in vivo robotic bioprinter
based on magnetic levitation are bioprinting of skin, cartilage
and bone. The nanotechnological strategies described above
could also be employed for designing more sophisticated
bioprinters for bioprinting more complex 3D human tissues
and organs such as kidney.
5. Conclusion and Future Perspectives
The research on the interface and integration of nan-
otechnology and tissue engineering is not just a highly
desirable dream or science fiction anymore, but rather a well-
established reality or already ongoing and rapidly expanding
globally funded project. Nanotechnology found in tissue
engineering field one of its most attractive, promising
and also socially sounded applications. From another side,
tissue engineers, by embracing nanotechnology, dramatically
increased their research arsenal, broadening their “toolkit,”
and were able to develop several novel impressive bioengi-
neering platform technologies by applying nanomaterials.
Thus, it is safe to predict that mutually beneficial collabora-
tion of nanotechnologists and tissue engineers will only con-
tinue to grow. Moreover, with time the difference between
these two professions will become increasingly semantic.
However, researches on the interface between nanotech-
nology and tissue engineering are still facing some serious
challenges.
The first and most obvious challenge is toxicology
of nanomaterials [55]. Although there are several solid
researches which established principal safety of certain
nanomaterials, the growing public concern about potential
toxicity of nanomaterials must be systematically addressed.
Thus, biocompatibility of nanomaterials for tissue engineer-
ing must be an integral part of the design principles as early
as on the stage of project ideation.
The second challenge is functionalization of nanomate-
rials. Recent advance in designing drug eluting nanofibers
using coaxial electrospinning is an excellent example of
desirable progress in this direction. Functionalization of
nanoparticles and carbon nanotubes is also under way.
The third challenge is design, synthesis, and fabrication
of novel nanomaterials with biomimetic properties. This
trend is already obvious in the fabrication of nanofibers using
electrospinning technology. A similar approach is highly
desirable for other forms of nanomaterials employed in tis-
sue engineering. Development of composite nanomaterials is
one of the most promising approaches in this direction.
The fourth challenge is standardization of nanomaterials.
The standardization on certain stage of development of any
emerging technology is a necessary step on the way
to industrial product certification. Standardization is
especially important in a biomedical application which
needs regulatory agencies approval of new products. Finally,
certain degree of standardization will enable comparing
research results.
The fifth and last (we believe the most important)
challenge is a seamless integration of nanomaterials into
macrolevel biofabrication technologies. The introduction of
nanomaterials will not reduce existing human organs size.
Although we already have demonstrated some impressive
examples of such integration, it is only the beginning and
even more exciting new technology platforms will emerge on
the interface between nanotechnology and biofabrication.
In the long term, perspective functional biomimetic
nanomaterials can enable regenerative medicine (healing
from inside) and thus reduce need for tissue engineering ex
vivo. Drug eluting electrospun vascular graft is one possible
example of this trend. Magnetic-forces-driven minimally-
invasive technologies for targeted delivery of bone tissue con-
structing nanomaterials and stem cells in vivo in myocardial
infarct area are other interesting examples. Finally, the in vivo
robotic bioprinter described in this review could transform
and reinvent surgical robotics.
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